Advances in targeted therapies for hepatocellular carcinoma in the genomic era
作者： Josep M. Llovet , Augusto Villanueva , Anja Lachenmayer , Richard S. Finn
DOI: 10.1038/NRCLINONC.2015.103
关键词: Clinical trial 、 Pathology 、 Intensive care medicine 、 Drug development 、 Hepatocellular carcinoma 、 Sorafenib 、 Phases of clinical research 、 Liver cancer 、 Medicine 、 Global health 、 Disease
摘要: … Patients with advanced-stage disease are candidates for treatment with sorafenib, a molecular targeted therapy with inhibitory activity against BRAF, VEGFRs and PDGFRs …
nature.com
core.ac.uk
sci-hub.se 参考文章(156)
Yasutoshi Muto, Hisataka Moriwaki, Mitsuo Ninomiya, Sadashi Adachi, Akiko Saito, Ken Takeshi Takasaki, Takuji Tanaka, Kaito Tsurumi, Masataka Okuno, Eiichi Tomita, Toshiyuki Nakamura, Takao Kojima, Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 334, pp. 1561- 1567 ,(1996) , 10.1056/NEJM199606133342402
Han Chong Toh, Pei-Jer Chen, Brian I. Carr, Jennifer J. Knox, Sharlene Gill, Peter Ansell, Evelyn M. McKeegan, Barry Dowell, Michelle Pedersen, Qin Qin, Jiang Qian, Frank A. Scappaticci, Justin L. Ricker, Dawn M. Carlson, Wei Peng Yong, Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma Cancer. ,vol. 119, pp. 380- 387 ,(2013) , 10.1002/CNCR.27758
Katrina Nicholes, Susan Guillet, Elizabeth Tomlinson, Kenneth Hillan, Barbara Wright, Gretchen D. Frantz, Thinh A. Pham, Lisa Dillard-Telm, Siao Ping Tsai, Jean-Philippe Stephan, Jeremy Stinson, Timothy Stewart, Dorothy M. French, A Mouse Model of Hepatocellular Carcinoma : Ectopic Expression of Fibroblast Growth Factor 19 in Skeletal Muscle of Transgenic Mice American Journal of Pathology. ,vol. 160, pp. 2295- 2307 ,(2002) , 10.1016/S0002-9440(10)61177-7
Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean-Frederic Blanc, Lunan Yan, Jijin Yang, Ligong Lu, Won-Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi-Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian B. Walters, Christine Dela Cruz, Valerie Poulart, Jian-Hua Wang, Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial Hepatology. ,vol. 60, pp. 1697- 1707 ,(2014) , 10.1002/HEP.27290
Maria Reig, Jordi Rimola, Ferran Torres, Anna Darnell, Carlos Rodriguez-Lope, Alejandro Forner, Neus LLarch, José Ríos, Carmen Ayuso, Jordi Bruix, Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design Hepatology. ,vol. 58, pp. 2023- 2031 ,(2013) , 10.1002/HEP.26586
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
Hans Popper, American Association for the Study of Liver Diseases: Symposium on Toxic Hepatic Injury Gastroenterology. ,vol. 38, pp. 786- 804 ,(1960) , 10.1016/S0016-5085(60)80094-7
Roberta Schmieder, Florian Puehler, Roland Neuhaus, Maria Kissel, Alex A Adjei, Jeffrey N Miner, Dominik Mumberg, Karl Ziegelbauer, Arne Scholz, Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma Neoplasia. ,vol. 15, pp. 1161- 1171 ,(2013) , 10.1593/NEO.13812
Dawang Zhou, Claudius Conrad, Fan Xia, Ji-Sun Park, Bernhard Payer, Yi Yin, Gregory Y. Lauwers, Wolfgang Thasler, Jeannie T. Lee, Joseph Avruch, Nabeel Bardeesy, Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene Cancer Cell. ,vol. 16, pp. 425- 438 ,(2009) , 10.1016/J.CCR.2009.09.026
Maria Reig, Ferran Torres, Carlos Rodriguez-Lope, Alejandro Forner, Neus LLarch, Jordi Rimola, Anna Darnell, José Ríos, Carmen Ayuso, Jordi Bruix, Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib Journal of Hepatology. ,vol. 61, pp. 318- 324 ,(2014) , 10.1016/J.JHEP.2014.03.030